Uro-gynecology

UTIPRO® PLUS AF

Medical Device

Intended use

Contact us

UTIPRO® PLUS AF

Utipro® Plus AF is intended for the control and prevention of urinary tract infections produced by pathogens such as E.coli and other gram (-) bacteria normally involved in the etiology of urological infections.

The compound, based on Xyloglucan (Hemicellulose) and Gelose, acts mechanically in the intestinal lumen, avoiding the contact of the pathogens with the intestinal mucosa, which is the first step for their proliferation and subsequent passage to the urinary tract.

Utipro® Plus AF is to be taken orally, from the appearance of the first symptoms of urinary tract disorders, with the aim of reducing the proliferation of pathogens that may degenerate into infections. In case of infection recurrences, Utipro® Plus AF is also intended for the prevention of new episodes, in which the proliferation of pathogen cause repeated urinary tract infection.

CE 0476

Utipro® Plus AF complies the Essential Requirements of Directive 93/42/EEC and subsequent amendments. 

Package

Utipro® Plus AF comes in capsule form, in blister packs (15 and 30 capsules).

Download leaflet

UTIPRO® PLUS AF around the world

Check it out

For more information, please

Contact us

Magazine

Scientific publication

We are happy to announce the publication of new evidence on the benefit of an antibiotic-free approach (xyloglucan, h…

News

We are happy to inform that Utipro® Plus AF is ready to land in Central Asia thanks to its very recent registration i…